ArticleBritish journal of cancer2019

Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.

Bertha A Brodin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.